Medicare Drug Price Negotiation is here to stay

At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis and Boehringer Ingelheim… The…

Read More

Links

Pharmaceutical clinical trials leaving Europe.Statistical Modeling, Causal Inference, and Social Science turns 20.Banach Fixed-Point Theorem explainedRecent health policy trends in California.AI scan for bone fractures approved by NHS.

Read More